Common errors of drug administration in infants: causes and avoidance

Area of Science:

• Pediatric Pharmacology
• Drug Safety
• Health Systems Analysis

Background:

• Infants face high drug exposure but lack pharmacokinetic/pharmacodynamic data, making them 'therapeutic orphans'.
• Existing drug formulations are often adult-centric, complicating pediatric dosing.
• Immature drug elimination, altered body composition, and size influence pediatric dose calculations.

Purpose of the Study:

• To highlight the prevalence and causes of drug administration errors in infants.
• To advocate for systemic changes to achieve a zero drug error rate in pediatric medication.
• To propose interventions for reducing medication errors in infants.

Main Methods:

• Analysis of drug administration error patterns in infants, particularly in intensive care settings.
• Review of existing systems from drug manufacture to administration.
• Adaptation of error reduction policies from industries like nuclear power and aviation.

Main Results:

• Dose errors are the most common drug administration errors in infants, frequently occurring in intensive care units.
• Drug errors are primarily a consequence of system flaws rather than individual mistakes.
• Preventive strategies can be implemented through comprehensive system analysis.

Conclusions:

• A zero drug error rate should be the goal, achieved by identifying and rectifying system faults.
• Interventions include developing child-specific formulations, pharmacist audits, clear prescriptions, and standardized dosing.
• General strategies like pediatric drug trials, education, and non-punitive error reporting are crucial.